Background
Methods
Study population
1978/79 | 1988/89 | 1996/97 | p-value* | |
---|---|---|---|---|
Included, n | 1937 | 2619 | 1254 | |
Men, n (%) | 215 (21.5) | 546 (20.8) | 279 (22.2) | 0.597 |
Mean age at time of fracture, men (95% CI) | 74.2 (73.3 – 75.2) | 76.6 (75.9 – 77.4) | 79.5 (78.4 – 80.6) | <0.001 |
Mean age at time of fracture, women (95% CI) | 76.8 (76.4 – 77.3) | 80.2 (79.8 – 80.6) | 81.4 (80.9 – 82.0) | <0.001 |
50-64 years, n (%) | 254 (13.1) | 170 (6.5) | 60 (4.8) | |
65-84 years, n (%) | 1322 (68.2) | 1606 (61.3) | 719 (57.3) | |
≥85 years, n (%) | 361 (18.6) | 843 (32.2) | 475 (37.9) | |
Intertrochanteric fractures, n (%) | 751 (38.8) | 1085 (41.4) | 563 (44.9) | 0.003 |
Median follow up time, years (range) | 4.9 (0–30.0) | 3.37 (0–20.0) | 3.63 (0–11.7) |
Study design
Data and definitions
Statistical analyses
Ethics and approvals
Results
Patient characteristics
Excess mortality within each cohort
Follow up time | Sex | Cohort | n | Dead, n (%) | Expected dead, n | SMR (95% CI) |
---|---|---|---|---|---|---|
0-6 months | Men | 78/79 | 417 | 105 (25.2) | 15.41 | 6.81 (4.47 – 8.35) |
88/89 | 546 | 137 (25.1) | 22.96 | 5.97 (4.90 – 7.13) | ||
96/97 | 279 | 72 (25.8) | 14.00 | 5.14 (3.90 – 6.61) | ||
Women | ||||||
78/79 | 1520 | 249 (16.4) | 48.74 | 5.11 (4.44 – 5.80) | ||
88/89 | 2073 | 371 (17.9) | 89.67 | 4.14 (3.68 – 4.61) | ||
96/97 | 975 | 156 (16.0) | 43.36 | 3.60 (2.99 – 4.26) | ||
6-12 months | Men | |||||
78/79 | 312 | 21 (6.7) | 12.41 | 1.69 (1.02 – 2.48) | ||
88/89 | 409 | 38 (9.3) | 18.80 | 2.02 (1.38 – 2.70) | ||
96/97 | 207 | 19 (9.2) | 11.03 | 1.72 (1.00 – 2.59) | ||
Women | ||||||
78/79 | 1271 | 76 (6.0) | 41.45 | 1.83 (1.42 – 2.28) | ||
88/89 | 1702 | 148 (8.7) | 75.42 | 1.96 (1.65 – 2.30) | ||
96/97 | 819 | 70 (8.5) | 38.19 | 1.83 (1.42 – 2.29) | ||
1-5 years | Men | |||||
78/79 | 291 | 129 (44.3) | 71.90 | 1.79 (1.47 - 2.18 ) | ||
88/89 | 371 | 208 (56.0) | 97.95 | 2.12 (1.82 – 2.47) | ||
96/97 | 188 | 95 (50.5) | 60.43 | 1.57 (1.26 – 1.96) | ||
Women | ||||||
78/79 | 1195 | 405 (33.9) | 285.68 | 1.42 (1.27 - 1.57) | ||
88/89 | 1554 | 701 (45.1) | 472.31 | 1.48 (1.37 - 1.61) | ||
96/97 | 749 | 342 (45.7) | 245.99 | 1.39 (1.24 - 1.55) | ||
5-10 years | Men | |||||
78/79 | 162 | 83 (51.2) | 54.17 | 1.53 (1.14 – 2..04) | ||
88/89 | 163 | 88 (54.0) | 54.77 | 1.61 (1.25 – 2..06) | ||
96/97 | 93 | 58 (62.3) | 33.56 | 1.73 (1.32 – 2.26) | ||
Women | ||||||
78/79 | 790 | 366 (46.3) | 255.16 | 1.43 (1.28 – 1.60) | ||
88/89 | 853 | 455 (53.3) | 318.87 | 1.42 (1.29 – 1.58) | ||
96/97 | 407 | 258 (63.3) | 146.69 | 1.76 (1.54 – 2.02) |
Follow up time | Age-group, years | Cohort | n | Dead, n (%) | Expected dead, n | SMR (95% CI) |
---|---|---|---|---|---|---|
0-6 months | 50-64 | |||||
78/79 | 254 | 7 (2.7) | 1.3 | 5.25 (1.62 – 9.57) | ||
88/89 | 170 | 10 (5.9) | 1.0 | 10.54 (4.53 – 17.86) | ||
96/97 | 60 | 4 (6.7) | 0.2 | 17.19 (3.66 – 37.53) | ||
65-84 | ||||||
78/79 | 1322 | 223 (16.9) | 35.2 | 6.33 (5.49 – 7.20) | ||
88/89 | 1606 | 257 (16.0) | 40.9 | 6.29 (5.49 - 7.15) | ||
96/97 | 719 | 107 (14.9) | 17.8 | 6.03 (4.88 – 7.28) | ||
≥ 85 | ||||||
78/79 | 361 | 124 (34.3) | 27.6 | 4.49 (3.67 – 5.38) | ||
88/89 | 843 | 241 (28.6) | 70.8 | 3.40 (2.94 – 3.90) | ||
96/97 | 475 | 117 (24.6) | 39.4 | 2.97 (2.43 – 3.60) | ||
6-12 months | 50-64 | |||||
78/79 | 247 | 4 (1.3) | 1.33 | 2.99 (0.68 – 16.25) | ||
88/89 | 160 | 3 (1.9) | 0.90 | 3.35 (0.00 -7.86) | ||
96/97 | 56 | 1 (1.8) | 0.22 | 4.54 (0.00-16.35) | ||
65-84 | ||||||
78/79 | 1099 | 64 (30.1) | 30.14 | 2.12 (1.62 – 2.67) | ||
88/89 | 1349 | 102 (7.6) | 36.64 | 2.78 (2.26 -3.33 ) | ||
96/97 | 612 | 39 (6.4) | 16.03 | 2.43 (1.70 -3.24 ) | ||
≥ 85 | ||||||
78/79 | 237 | 29 (12.2) | 22.39 | 1.30 (0.85- 1.81) | ||
88/89 | 602 | 81 (13.5) | 56.68 | 1.43 (1.13 – 1.76) | ||
96/97 | 358 | 49 (13.7) | 32.97 | 1.49 (1.09 – 1.93) | ||
1-5 years | 50-64 | |||||
78/79 | 243 | 31 (12.8) | 11.79 | 2.63 (1.75 -3.59 ) | ||
88/89 | 157 | 28 (17.8) | 7.41 | 3.78 (2.46 – 5.31) | ||
96/97 | 55 | 7 (12.7) | 2.03 | 3.45 (1.12 – 6.47) | ||
65-84 | ||||||
78/79 | 1035 | 363 (35.1) | 224.54 | 1.62 (1.45 – 1.80) | ||
88/89 | 1247 | 533 (42.7) | 260.07 | 2.05 (1.87 - 2.24) | ||
96/97 | 573 | 226 (39.4) | 120.21 | 1.88 (1.64 – 2.15) | ||
≥ 85 | ||||||
78/79 | 208 | 140 (0.67) | 121.25 | 1.36 (0.97 – 1.37) | ||
88/89 | 521 | 348 (66.8) | 302.79 | 1.15 (1.03 – 1.28) | ||
96/97 | 309 | 204 (66.0) | 184.18 | 1.11 (0.97 - 1.27) | ||
5-10 years | 50-64 | |||||
78/79 | 212 | 36 (17.0) | 17.94 | 2.01 (1.38 – 2.74) | ||
88/89 | 129 | 28 (21.7) | 9.99 | 2.80 (1.81 – 3.93) | ||
96/97 | 48 | 10 (20.8) | 2.91 | 3.44 (1.51 – 5.91) | ||
65-84 | ||||||
78/79 | 672 | 359 (53.4) | 233.11 | 1.54 (1.38 – 1.72) | ||
88/89 | 714 | 363 (50.8) | 233.4 | 1.55 (1.40 – 1.73) | ||
96/97 | 347 | 213 (61.4) | 106.23 | 2.01 (1.74 – 2.31) | ||
≥ 85 | ||||||
78/79 | 68 | 54 (79.4) | 58.29 | 0.93 (0.66 – 1.32) | ||
88/89 | 173 | 152 (87.9) | 130.22 | 1.17 (0.98 – 1.38) | ||
96/97 | 105 | 93 (88.6) | 71.11 | 1.31 (1.07 – 1.61) |
Follow up time | Fracture type | Cohort | n | Dead, n (%) | Expected dead, n | SMR (95% CI) |
---|---|---|---|---|---|---|
0-6 months | Femoral neck | |||||
78/79 | 1185 | 203 (17.1) | 36.7 | 5.53 (4.76 – 6.37) | ||
88/89 | 1534 | 263 (17.1) | 62.6 | 4.20 (3.66 – 4.76) | ||
96/97 | 691 | 127 (18.4) | 30.2 | 4.21 (3.44 – 5.05) | ||
Inter-trochanteric | ||||||
78/79 | 751 | 151 (20.1) | 27.4 | 5.51 (4.61 – 6.52) | ||
88/89 | 1085 | 245 (22.6) | 50.0 | 4.90 (4.23 – 5.63) | ||
96/97 | 563 | 101 (17.9) | 27.2 | 3.71 (2.95 – 4.56) | ||
6-12 months | Femoral neck | |||||
78/79 | 982 | 61 (6.2) | 30.55 | 2.00 (1.50 – 2..52) | ||
88/89 | 1271 | 105 (8.3) | 51.89 | 2.02 (1.64 – 2.43) | ||
96/97 | 564 | 46 (8.2) | 25.53 | 1.80 (1.30 – 2.36) | ||
Inter-trochanteric | ||||||
78/79 | 600 | 36 (6.0) | 23.31 | 1.54 (1.05 – 2.10) | ||
88/89 | 840 | 81 (9.6) | 42.33 | 1.91 (1.51 – 2.36) | ||
96/97 | 462 | 43 (9.3) | 23.69 | 1.82 (1.29 – 2.41) | ||
1-5 years | Femoral neck | |||||
78/79 | 921 | 312 (33.9) | 205.26 | 1.52 (1.32 – 1.71) | ||
88/89 | 1166 | 527 (45.2) | 325.74 | 1.62 (1.47 – 1.77) | ||
96/97 | 518 | 224 (43.2) | 161.04 | 1.39 (1.21 – 1.60) | ||
Inter-trochanteric | ||||||
78/79 | 564 | 221 (39.2) | 152.31 | 1.45 (1.25 – 1.67) | ||
88/89 | 759 | 382 (50.3) | 244.52 | 1.56 (1.39 – 1.75) | ||
96/97 | 419 | 213 (50.8) | 145.39 | 1.47 (1.27 – 1.69) | ||
5-10 years | Femoral neck | |||||
78/79 | 609 | 260 (42.7) | 191.54 | 1.36 (1.19 – 1.54) | ||
88/89 | 639 | 322 (50.4) | 229.64 | 1.40 (1.25 – 1.57) | ||
96/97 | 294 | 176 (59.9) | 99.77 | 1.76 (1.52 – 2.07) | ||
Inter-trochanteric | ||||||
78/79 | 343 | 189 (55.1) | 117.78 | 1.60 (1.35 – 1.90) | ||
88/89 | 377 | 221 (58.6) | 144.01 | 1.53 (1.32 – 1.79) | ||
96/97 | 206 | 140 (68.0) | 80.48 | 1.74 (1.45 – 2.10) |
Age-group, years | Cohort | n | Dead, n (%) | Expected dead, n | SMR (95% CI) | |
---|---|---|---|---|---|---|
Men | 50-64 | |||||
78/79 | 74 | 3 (4.1) | 1.26 | 2.38 (0.00 - 5.58) | ||
88/89 | 63 | 5 (7.9) | 0.99 | 5.05 (1.02 - 10.42) | ||
96/97 | 22 | 2 (9.1) | 0.23 | 8.76 (0.00 - 26.70) | ||
65-84 | ||||||
78/79 | 281 | 93 (33.1) | 17.13 | 5.43 (4.30 - 6.74) | ||
88/89 | 363 | 117 (32.2) | 22.19 | 5.27 (4.27 - 6.41) | ||
96/97 | 170 | 43 (25.3) | 10.92 | 3.94 (2.76 - 5.29) | ||
≥ 85 | ||||||
78/79 | 62 | 30 (48.4) | 3.18 | 3.18 (2.00 – 4.93) | ||
88/89 | 120 | 53 (44.2) | 2.85 | 2.85 (2.07 – 3.84) | ||
96/97 | 87 | 46 (52.9) | 3.31 | 3.31 (2.30 – 4.70) | ||
Women | 50-64 | |||||
78/79 | 180 | 8 (4.4) | 1.41 | 5.67 (2.10 – 10.02) | ||
88/89 | 107 | 8 (7.5) | 0.85 | 9.36 (3.42 – 16.76) | ||
96/97 | 38 | 3 (7.9) | 0.22 | 13.37 (0.00 – 32.24) | ||
65-84 | ||||||
78/79 | 1041 | 194 (18.6) | 48.22 | 4.02 (3.45 – 4.64) | ||
88/89 | 1243 | 242 (19.5) | 55.33 | 4.37 (3.82 – 4.97) | ||
96/97 | 549 | 103 (18.8) | 22.86 | 4.51 (3.62 – 5.48) | ||
≥ 85 | ||||||
78/79 | 299 | 123 (41.1) | 40.56 | 3.03 (2.46 – 3.68) | ||
88/89 | 723 | 269 (37.2) | 108.90 | 2.47 (2.16 – 2.82) | ||
96/97 | 388 | 120 (30.9) | 58.47 | 2.05 (1.69 – 2.46) |
Secular changes in excess mortality from 1978 to 1997
Duration of excess mortality
Sex | Age-group, years | Cohort | Included, n | Duration of excess mortality, years |
---|---|---|---|---|
Men | ||||
50-64 | 78/79 | 74 | 6 | |
88/89 | 63 | 9 | ||
96/97 | 22 | 3 | ||
65-84 | 78/79 | 281 | 15 a)
| |
88/89 | 363 | 11 | ||
96/97 | 170 | >10 b)
| ||
≥ 85 | 78/79 | 62 | 3 | |
88/89 | 120 | 3 | ||
96/97 | 87 | 2 | ||
Women | 50-64 | 78/79 | 180 | 17 |
88/89 | 107 | 12 | ||
96/97 | 38 | 9 | ||
65-84 | 78/79 | 1041 | >19 a)
| |
88/89 | 1243 | 14 | ||
96/97 | 549 | 10 | ||
≥ 85 | 78/79 | 299 | 3 | |
88/89 | 723 | 7 | ||
96/97 | 388 | 8 |